Endpoint definition
↥| Name | C3_KAPOSI_SARCOMA |
|---|---|
| Long name | Kaposi sarcoma |
| Hospital Discharge registry | ICD-10: C46 |
| Cause of Death registry | ICD-10: C46 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF4 |
| Latin name | Sarcoma Kaposi |
Kaposi sarcoma
Kaposi's sarcoma: A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21 | - | 16 |
| Unadjusted prevalence (%) | 0.01 | - | 0.02 |
| Mean age at first event (years) | 63.02 | - | 61.83 |
| Case fatality at 5-years (%) | 19.05 | - | 12.50 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | - | 2.5 |
| Recurrence at 6 months (%) | 42.86 | - | 50.00 |
Survival analyses between endpoints
↥Plot
before Kaposi sarcoma
after Kaposi sarcoma
Loading survival analyses plot…
Table
Loading survival analyses table…